ROKU insider filing: 25,000 shares for sale on NASDAQ
Rhea-AI Filing Summary
ROKU filed a Form 144 notifying the proposed sale of 25,000 common shares, with an aggregate market value of $2,080,250.00, listed for sale on NASDAQ with an approximate sale date of 08/11/2025. The shares are held with Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY).
The filing states the shares were acquired on 06/14/2013 through previously exercised stock options from the issuer and paid in cash. The document also discloses three prior 10b5-1 sales of 25,000 shares each on 05/29/2025, 06/10/2025, and 07/10/2025, with gross proceeds of $1,875,000.00, $2,006,850.00, and $2,241,062.50 respectively. The filing reports 130,251,569 shares outstanding.
Positive
- Planned sale disclosed: Proposed sale of 25,000 common shares with aggregate market value $2,080,250.00.
- Acquisition details provided: Shares acquired on 06/14/2013 via previously exercised stock options and paid in cash.
- Broker identified: Morgan Stanley Smith Barney LLC listed as the executing broker.
- Prior 10b5-1 sales disclosed: Three 25,000-share sales on 05/29/2025, 06/10/2025, and 07/10/2025 with gross proceeds stated.
Negative
- None.
Insights
TL;DR Routine Form 144 disclosing a planned sale of 25,000 ROKU shares and prior 10b5-1 sales over the past three months.
The filing explicitly reports a proposed sale of 25,000 common shares with an aggregate market value of $2,080,250.00, scheduled approximately for 08/11/2025, executed through Morgan Stanley Smith Barney LLC. Acquisition details show the shares were obtained via previously exercised stock options on 06/14/2013 and paid in cash. The document also lists three prior 10b5-1 sales of 25,000 shares each on 05/29/2025, 06/10/2025, and 07/10/2025, with provided gross proceeds. This is a straightforward disclosure of intended insider selling without additional operational or financial data in the filing.
TL;DR The filer made compliant disclosures under Rule 144 and identified a broker and prior 10b5-1 transactions.
The form includes the broker name and address, the acquisition method (previously exercised stock options) and payment method (cash), and a representation regarding absence of undisclosed material adverse information. It also provides specific past-sale entries labeled as 10b5-1 sales with dates and gross proceeds. The filing contains no statements about issuer operations or other governance changes; it focuses on sale logistics and required attestations.
FAQ
What does the ROKU Form 144 show about the proposed sale?
Who is the broker listed for the proposed sale on the Form 144?
Were there any recent insider sales disclosed in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.